Full View

Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use

V Iyer, HS Singh, JA Reiffel - Journal of cardiovascular …, 2012 - journals.sagepub.com
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach
epidemic proportions as the US population ages. The presence of AF increases lifetime …
被引用次数：14 相关文章

Dabigatran: Comparison to Warfarin, Pathway to Approval, and Practical Guidelines for Use.

V Iyer, HS Singh, JA Reiffel - Journal of Cardiovascular …, 2012 - search.ebscohost.com
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach
epidemic proportions as the US population ages. The presence of AF increases lifetime …

Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use

V Iyer, HS Singh, JA Reiffel - Journal of cardiovascular …, 2012 - pubmed.ncbi.nlm.nih.gov
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach
epidemic proportions as the US population ages. The presence of AF increases lifetime …

Dabigatran: comparison to warfarin, pathway to approval, and practical guidelines for use.

V Iyer, HS Singh, JA Reiffel - Journal of Cardiovascular …, 2012 - europepmc.org
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach
epidemic proportions as the US population ages. The presence of AF increases lifetime …

Dabigatran: Comparison to Warfarin, Pathway to Approval, and Practical Guidelines for Use.

V Iyer, HS Singh, JA Reiffel - Journal of Cardiovascular …, 2012 - search.ebscohost.com
Atrial fibrillation (AF) affects more than 3 million Americans and is expected to reach
epidemic proportions as the US population ages. The presence of AF increases lifetime …